A study of the polymorphism RS9939609 of the FTO gene and RS738409 of the PNPLA3 gene as risk factors for the development of NAFLD in the Yakut population of type 2 diabetes mellitus
https://doi.org/10.25789/YMJ.2018.63.05
Abstract
In order to study the distribution frequency of the polymorphism alleles rs9939609 of the FTO gene and polymorphism rs738409 of the PNPLA3 gene among the Yakuts, DNA samples of type 2 diabetes patients and healthy volunteers were tested.
The study of the distribution frequency of the polymorphism alleles rs9939609 of the FTO gene and polymorphism rs738409 of the PNPLA3 gene in both groups showed no significant differences. Analysis of the distribution frequency of alleles and genotypes of the polymorphic variant of the FTO gene (rs9939609) in the group of patients with type 2 diabetes and healthy revealed a predominance of the T allele and a homozygous genotype of TT, except for a group of practically healthy men, which despite the prevalence of the T allele was characterized by the highest level of the heterozygous genotype AT. At analyzing the distribution frequency of the alleles and genotypes of the polymorphic version of the PNPLA3 gene (rs738409), the allele G and the homozygous genotype GG prevailed in both groups. In the studied men of both groups the G allele significantly prevailed over the C allele (p <0.05).
About the Authors
N. I. PavlovaRussian Federation
Pavlova Nadezhda Ivanovna – PhD (Biology), leading researcher, head of the laboratory of hereditary pathology; doctor laboratory assistant of the Scientific Clinical Diagnostic Laboratory
N. A. Solovyeva
Russian Federation
Soloveva Natalia Alekseevna – PhD, senior researcher, laboratoriy of population genetics
A. T. Dyakonova
Russian Federation
Dyakonova Alexandra Timofeevna - Jr. researcher, laboratory of hereditary pathology
N. P. Filippova
Russian Federation
Filippova Natalia Pavlovna - PhD (Biology), associate professor, scientific researcher, laboratory of population genetics
V. V. Dodokhov
Russian Federation
Dodokhov Vladimir Vladimirovich - PhD (Biology), senior researcher, laboratory of hereditary pathology; Senior Lecturer of the Department
phone: 89248760599
M. A. Varlamova
Russian Federation
Varlamova Marina Alekseevna - researcher, laboratory of hereditary pathology
Kh. A. Kurtanov
Russian Federation
Kurtanov Khariton Alekseevich - PhD, Chief Scientific Officer - Head of the Department of Molecular Genetics
References
1. Birjukova E.V. Diabetes mellitus type 2 and non-alcoholic fatty liver disease – diseases of the present / E.V Birjukova, S.V. Rodionova // Medical almanac. – 2017. – № 6 (51) – P.130-135.
2. Dedov I.I. Epidemiology of diabetes mellitus in the Russian Federation: clinical and statistical report on the Federal Register of Diabetes Mellitus / I.I. Dedov, M.V. Shestakova, O.K. Vikulova // Diabetes. – 2017. – Vol. 20, №1. – P.13-41. doi: 10.14341/DM8664.
3. Pashenceva A.V. Insulin resistance in the therapeutic clinic / A.V. Pashenceva, A.F. Verbovoj, L.A. Sharonova // Obesity and metabolism. – 2017. – № 14(2). – P. 9–17.
4. Razina A.O. Obesity: a modern view of the problem / A.O. Razina, E.E. Achkasov, S.D. Runenko // Obesity and metabolism. – 2016. – № 13(1). – P. 3-8. doi: 10.14341/OMET201613-8.
5. Phenotypic manifestations of polymorphism rs 9939609 of the FTO gene in a mother-child dyad / N.M. Shilina [et al.] // Questions of children’s dietology. – 2017. – № 15(4). – P. 14–20. doi: 10.20953/1727-5784-2017-4-14-20.
6. Association of PNPLA3 SNP rs738409 with liver density in africanamericans with type 2 diabetes mellitus / AJ. Cox, MR. Wing, JJ. Carr [et al.] // Diabetes & metabolism. – 2011. – Vol. 37,№5. – P.452-455. doi:10.1016/j.diabet.2011.05.001.
7. Association of FTO rs9939609 SNP with Obesity and Obesity– Associated Phenotypes in a North Indian Population / J. Prakash [et al.] // Oman Medical Journal. – 2016. – Vol. 31, № 2. – р. 99-106.
8. Costs and consequence associatiated with newer medications for glycemic control in type 2 diabetes / A. Sinha, M. Ragan, T. Hoerger [et al.] // Diabetes Care.– 2010.– Vol. 33.– P. 695–700.
9. Kan H. Influence of the rs738409 polymorphism in patatin-like phospholipase 3 on the treatment efficacy of non-alcoholic fatty liver disease with type 2 diabetes mellitus / H. Kan, H. Hyogo, H. Ochi // Hepatol Res.– 2016 – Vol.46– E146–E153. doi: 10.1111/hepr.12552.
10. PNPLA3 I148M polymorphism and progressive liver disease / P. Dongiovanni [et al.] // World Journal of Gastroenterology. – 2013. – Vol. 19. – №41. – P. 6969-6978.
11. Specifically PNPLA3-Mediated Accumulation of Liver Fat in Obese Patients with Type 2 Diabetes / J-M. Petit, B. Guiu, D. Masson, L. [et al.] // The Journal of Clinical Endocrinology & Metabolism. – 2010. – Vol. 95.– №12.– P.E430– E436 https://doi.org/10.1210/jc.2010-0814
12. The genetics of obesity: practical implications / J. Hebebrand [et al.] // Int J Obes Relat Metab Disord. – 2001. – № 25. – р. 10–17.
13. The impact of PNPLA3 and JAZF1 on hepatocellular carcinoma in non-viral hepatitis patients with type 2 diabetes mellitus/ M. Ueyama, N. Nishida, M. Korenaga [et al.] //J Gastroenterol. –2015.– Vol.51(4).– 370-9. doi: 10.1007/s00535-015-1116-6. Epub 2015 Sep 3.
Review
For citations:
Pavlova N.I., Solovyeva N.A., Dyakonova A.T., Filippova N.P., Dodokhov V.V., Varlamova M.A., Kurtanov Kh.A. A study of the polymorphism RS9939609 of the FTO gene and RS738409 of the PNPLA3 gene as risk factors for the development of NAFLD in the Yakut population of type 2 diabetes mellitus. Yakut Medical Journal. 2018;(3):18-21. https://doi.org/10.25789/YMJ.2018.63.05